Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Knowing when to choose investing over saving can significantly enhance your wealth. Discover strategies to make informed financial decisions.
23,985 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
SpaceX investor hype meets timeless Buffett wisdom. These Warren Buffett quotes must guide your SpaceX stock decision...
Is Micron stock a smart move when it trades under $500? This guide breaks down the AI memory market, Micron's role, a...
SoFi shareholders have faced a tough year, but a pair of upbeat bank results offers a new tailwind. This article brea...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
At CES 2026, Jensen Huang highlighted memory as AI's key bottleneck. This shift sent memory stocks like Micron and Sa...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
When a notable small-cap manager exits a large stake in a data-security firm, it creates questions for investors. Thi...
A viral Substack piece by a former EMT triggered rapid stock declines as AI fears spread. This article explains what ...
As market conditions shift in March 2026, traders seek better tools and pricing. This guide highlights the best SoFi ...